| ATMP | Advanced therapy medicinal product |
| TMJ-OA | Temporomandibular joint osteoarthritis |
| TMJ | Temporomandibular joint |
| TMD | Temporomandibular disorder |
| ABS | Treatment group 1: AB Serum |
| HA | Treatment group 2: Hyaluronic acid |
| STx. | Treatment group 3: Mesenchymal stromal cells (Oxacells HP) |
| HA + STx. | Treatment group 4: Hyaluronic acid + Mesenchymal stromal cells (Oxacells HP) |
| TMJD | Temporomandibular joint disorders |
| RDC | Research Diagnostic Criteria |
| TENS | Transcutaneous electrical nerve stimulation |
| NSAID | Non-steroidal anti-inflammatory drugs |
| PRP | Platelet Rich Plasma |
| MSC | Mesenchymal stromal cells |
| ESC | Embryonic stromal cells |
| ISCT | International Society for Cellular Therapy |
| ASC | Adipose-derived stromal cells |
| SVF | Stromal vascular fraction |
| BEI | Back-scattered electron imaging |
| AC | Articular cartilage |
| SMZ | Subchondral mineralized zone |
| GAG | Glycosaminoglycans |
| ADSC | Adipose tissue-derived stromal cells |
| PDLSC | Periodontal ligament stromal cells |
| SCAP | Stromal cells from apical papilla |
| DFPC | Dental follicle progenitor cells |
| DPSC | Dental pulp stromal cells |
| MPC | Mesenchymal progenitor cells |
| hMSC | Human mesenchymal stromal cells |
| ACLT | Anterior cruciate ligament transaction |
| PBS | Phosphate-buffered saline |
| PMMA | Polymethylmethacrylate |